These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25338546)

  • 1. Quality and efficiency of statin prescribing across countries with a special focus on South Africa: findings and future implications.
    Godman B; Bishop I; Campbell SM; Malmström RE; Truter I
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):323-30. PubMed ID: 25338546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
    McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
    Bennie M; Godman B; Bishop I; Campbell S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
    Fuksa L; Vocelka M; Vytrisalova M
    Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.
    Godman B; Burkhardt T; Bucsics A; Wettermark B; Wieninger P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):475-84. PubMed ID: 19817531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost-Benefit Balance of Statins in Hawai'i: A Moving Target.
    Lum CJ; Nakagawa K; Shohet RV; Seto TB; Taira DA
    Hawaii J Med Public Health; 2017 Apr; 76(4):99-102. PubMed ID: 28428922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
    Geleedst-De Vooght M; Maitland-van der Zee AH; Schalekamp T; Mantel-Teeuwisse A; Jansen P
    Drugs Aging; 2010 Jul; 27(7):589-96. PubMed ID: 20583852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
    Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
    Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi.
    Abuelkhair M; Abdu S; Godman B; Fahmy S; Malmström RE; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):115-24. PubMed ID: 22280201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future.
    Akunne OO; Godman B; Adedapo AD; Truter I; Fadare J
    J Comp Eff Res; 2016 May; 5(3):281-8. PubMed ID: 27097045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications.
    Woerkom Mv; Piepenbrink H; Godman B; Metz Jd; Campbell S; Bennie M; Eimers M; Gustafsson LL
    J Comp Eff Res; 2012 Nov; 1(6):527-38. PubMed ID: 24236472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications.
    Leporowski A; Godman B; Kurdi A; MacBride-Stewart S; Ryan M; Hurding S; Do Nascimento RC; Bennie M; Morton A
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):655-666. PubMed ID: 30014725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European countries with small populations can obtain low prices for drugs: Lithuania as a case history.
    Garuoliene K; Godman B; Gulbinovič J; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):343-9. PubMed ID: 21671703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications.
    Truter I; Shankar S; Bennie M; Woerkom Mv; Godman B
    J Comp Eff Res; 2015 Mar; 4(2):123-31. PubMed ID: 25825841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy, safety, and pharmaco-economical aspects of the therapy for dyslipidemia with brand-name and generic statins].
    Ol'binskaia LI; Danilogorskaia IuA
    Ter Arkh; 2003; 75(12):47-50. PubMed ID: 14959470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction.
    Coma A; Zara C; Godman B; Agustí A; Diogène E; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):569-81. PubMed ID: 19941434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa.
    de Jager H; Suleman F
    Int J Clin Pharm; 2019 Feb; 41(1):81-87. PubMed ID: 30478491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using lower cost statins improves outcomes for normal cholesterol non-diabetic patients.
    Arbel R; Greenberg D
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):495-501. PubMed ID: 28277855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.